跳至主要内容
临床试验/NCT02238990
NCT02238990进行中(未招募)不适用

Biomarkerscreening Via Transcriptome and Methylosome Analysis in Cervical Cancer and Its Preinvasive Lesions

University of Luebeck1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100
试验地点
1
主要终点
CIN III (cervical intraepithelial neoplasia) lesions

研究概览

简要总结

The following trial is a multicenter and prospective research trial of the colposcopy unit of luebeck university and the national research center in Borstel, Germany.

The study is to identify and evaluate new biomarkers in human papilloma virus (HPV) associated malignancies and its preinvasive lesions of the cervix uteri. Fresh tissue samples being removed during conizations and/or hysterectomies are to be fixed in HOPE's solution and analyzed according to their transcriptomes and methylosome. The hereby found candidates are to be validated using immunohistochemistry and RT [real-time] -PCR [polymerase chain reaction].

The project is meant to be followed by continuous studies developing a new test describing the malignant potential of HPV associated genital lesions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Positive informed consent
  • Patients with suspected preinvasive genital lesion
  • Patients with confirmed genital lesion (both preinvasive and invasive)
  • Contact via dept. of obs/gyn of luebeck university
  • Complete set of data

排除标准

  • Incomplete set of data
  • Negative informed consent

结局指标

主要结局

CIN III (cervical intraepithelial neoplasia) lesions

时间窗: three years

number of CIN III lesions

cervical cancer

时间窗: three years

number of cervical cancer probes

HPV

时间窗: three years

number and type of HPV infection of the analyzed probes

次要结局

未报告次要终点

研究者

发起方
University of Luebeck
申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Alexander Beyer

Priv.-Doz.Dr.med.habil.

University of Luebeck

研究点 (1)

Loading locations...

相似试验